Kenya and the United States have reaffirmed their commitment to strengthening collaboration in healthcare systems, pharmaceutical manufacturing, and medical commodity security. In a strategic meeting at the Kenya Medical Supplies Authority (KEMSA), Cabinet Secretary for Health Dr. Deborah Mlongo Barasa hosted a U.S. Congressional Delegation to discuss critical areas of cooperation aimed at enhancing Kenya’s self-reliance in healthcare.
Dr. Barasa emphasized Kenya’s commitment to reducing dependence on imported medical supplies by boosting local pharmaceutical manufacturing. She outlined government initiatives to attract private-sector investment, enhance quality assurance, and streamline regulatory frameworks to position Kenya as a regional hub for health commodities.
“The goal is to achieve self-sufficiency in healthcare commodity procurement while ensuring access to high-quality and affordable medicines for all Kenyans,” Dr. Barasa stated. “With U.S. support in technology transfer, supply chain management, and market access, we can build a more resilient and efficient healthcare system.”
The U.S. delegation acknowledged Kenya’s progress and pledged continued support in areas such as capacity building, regulatory strengthening, and expanding trade partnerships. Discussions also focused on leveraging digital solutions for supply chain transparency, improving emergency response mechanisms, and fostering long-term investment in Kenya’s health sector.
KEMSA Board Chair Mr. Samuel Tunai and CEO Dr. Waqo Ejersa provided insights into ongoing reforms at the authority aimed at enhancing efficiency, accountability, and service delivery in medical supply distribution.
Both parties reiterated their shared commitment to a sustainable, high-quality healthcare system, positioning Kenya as a leader in regional health security. The meeting marked another step forward in Kenya-U.S. relations, paving the way for deeper partnerships in public health innovation and economic growth.
